![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 42, 29683-29688, October 15, 1999
From the Department of Biochemistry, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157
| |
ABSTRACT |
|---|
|
|
|---|
In addition to the CDP-choline pathway for
phosphatidylcholine (PC) synthesis, the liver has a unique
phosphatidylethanolamine (PE) methyltransferase activity for PC
synthesis via three methylations of the ethanolamine moiety of PE.
Previous studies indicate that the two pathways are functionally
different and not interchangeable even though PC is the common product
of both pathways. This study was designed to test the hypothesis that
these two pathways produce different profiles of PC species. The PC
species from these two pathways were labeled with specific stable
isotope precursors, D9-choline and D4-ethanolamine, and analyzed by
electrospray tandem mass spectrometry. Our studies revealed a profound
distinction in PC profiles between the CDP-choline pathway and the PE
methylation pathway. PC molecules produced from the CDP-choline pathway
were mainly comprised of medium chain, saturated (e.g.
16:0/18:0) species. On the other hand, PC molecules from the PE
methylation pathway were much more diverse and were comprised of
significantly more long chain, polyunsaturated (e.g.
18:0/20:4) species. PC species from the methylation pathway contained a
higher percentage of arachidonate and were more diverse than those from
the CDP-choline pathway. This profound distinction of PC profiles may
contribute to the different functions of these two pathways in the liver.
Phosphatidylcholine
(PC)1 is a major group of
phospholipid in all mammalian cells (1). PC is comprised of hydrocarbon
chains attached to glycerophosphocholine via acyl, alkyl, or alkenyl linkages. The molecular diversity of PC and other phospholipids is
dictated by the combination of different lengths, number of double
bonds, and types of linkages of hydrocarbon chains. As a result, a
single mammalian cell contains at least a thousand species of
phospholipids (2). In most mammalian cells, PC is synthesized
mainly via the CDP-choline pathway (3). This pathway uses choline as an
initial substrate and is catalyzed by three enzymes: choline kinase,
CTP:phosphocholine cytidylyltransferase (CT), and cholinephosphate
transferase, with CT as the rate-limiting enzyme (1). Hepatocytes are
unique because they also possess a high activity of
phosphatidylethanolamine methyltransferase (PEMT) that converts
PE to PC via three sequential steps of methylation (4) in addition to a
high level of CDP-choline pathway activity. The significance of the
PEMT pathway is not completely understood (5).
The PEMT pathway seems redundant because its product, PC, is also
synthesized by the CDP-choline pathway in hepatocytes. Therefore, the
PEMT pathway is traditionally considered a backup pathway for PC
synthesis in hepatocytes (3). However, recent studies indicate that
these two pathways apparently have opposite effects on proliferative
characteristics of the liver and liver-derived cell lines (6-10).
These studies suggest that the higher activity of the CDP-choline
pathway favors the faster proliferation of hepatocytes. Conversely,
expression of PEMT strongly inhibits the growth of hepatoma cell lines
and is negatively associated with the developmental growth of liver and
with neoplastic growth of liver tumor induced by chemical carcinogens
(6-10).
Recombinant expression of PEMT in cultured cell lines leads to an
active synthesis of PC via PE methylation (11). However, the PC
synthesized via this methylation pathway does not substitute for the
role of PC synthesized from the CDP-choline pathway (12). MT58 is a
cell line derived from Chinese hamster ovary (CHO) K1 cells by chemical
mutagenesis and carries a temperature-sensitive mutation in the
rate-limiting enzyme, CT, of the CDP-choline pathway (13). At the
non-permissive temperature, CT becomes inactive, PC synthesis shuts
down, and the mutant dies via apoptosis. Recombinant expression of rat
liver CT rescues the mutant effectively, whereas recombinant expression
of rat liver PEMT fails to rescue MT58 cells at the non-permissive
temperature (12). Apparently the roles of the CDP-choline pathway and
the PEMT pathway are distinct and not interchangeable. One hypothesis
for this distinction is that PC synthesized from different pathways may
have different subcellular locations. The ability of exogenous PC to
rescue the mutant phenotype (14) suggests, however, that PC synthesized at one subcellular location is unlikely to be restricted from moving
freely to another subcellular location. Thus, the hypothesis of
distinctive localization of PC is an unlikely explanation for why PEMT
fails to rescue the mutant.
Another hypothesis is that the two pathways synthesize different pools
of PC molecular species. To test this hypothesis, we devised a novel
strategy capable of specifically displaying the PC species derived from
the CDP-choline pathway and the PEMT pathway. We report here that the
PC species synthesized from the CDP-choline pathway were mainly
comprised of medium chain and saturated species, whereas the PC species
derived from the methylation pathway are mainly comprised of long chain
and highly unsaturated species. Our study suggests that the difference
in PC composition contributes to the functional distinction between the
two pathways.
Materials--
D4-ethanolamine and D9-choline chloride
were from Isotec, Inc. [3H]ethanolamine was from American
Radiolabeled Chemicals, Inc. Dulbecco's modified essential medium
(MEM) and fetal bovine serum were from Life Technologies, Inc. Silica
gel H plates were from Analtech, Inc. Phospholipid standards were from
Avanti Polar Lipids. All other chemicals and materials were from Fisher Scientific.
Cell Culture--
Rat primary hepatocytes were obtained by
collagenase perfusion (15). Hepatocytes were cultured on
collagen-coated culture dishes overnight prior to experiments in
Dulbecco's MEM with 10% fetal bovine serum, 10 µg/ml insulin, and
10 mM Hepes buffer. McArdle RH7777 cells were dually
transfected with 10 µg of pCMV5/PEMT2 (11) and 1 µg of pSV2neo
plasmid by calcium phosphate precipitation as described (16).
G418-resistent colonies were selected with 500 µg/ml G418 and
maintained in 200 µg/ml G418.
Incorporation of Tritium-labeled Precursors into
PC--
3.5 × 105 cells were labeled with 1 µCi/ml
each, [3H]choline chloride, or
[3H]ethanolamine HCl for 24 h in low choline
medium (choline-free MEM + 2% fetal bovine serum). Cells were scraped
into methanol, and lipids were extracted according to Bligh and Dyer
(17). The lipid extracts were separated on silica gel H plates in a solvent system of 65/35/8 chloroform/methanol/ammonium hydroxide. The
phospholipid bands were visualized by iodine vapor and the PC and PE
bands were scraped and counted by scintillation counter.
Deuterium Labeling and Mass Spectrometry--
3.5 × 105 cells were incubated in low choline medium containing
50 µg/ml D9-choline chloride and 50 µg/ml D4-ethanolamine for 24 h or otherwise noted. Cells were scraped into methanol and lipids were extracted. Extracts were measured for lipid phosphorus content (18). Lipid extract equaling 500 pmol total lipid phosphorus in
100 µl of 2:1 methylene chloride:methanol was analyzed on a Micromass
Quattro II triple quadruple mass spectrometer (Micromass, United
Kingdom) in a solvent system of 45/45/10 methylene
chloride/methanol/H2O. Data were acquired using MassLynx NT
software (Micromass Limited, United Kingdom). A mixture of di-14:0,
di-16:0, 16:0-18:1, and di-20:4 PC standards of equal concentration
was used to determine instrument settings and concentration for
optimal signal intensities. Standards and samples contained 1% formic
acid for positive ion analysis, and 1% ammonium hydroxide for negative
ion analysis. PC molecular species were detected by precursor ion
scanning for m/z +184, +188, and +193 in the
positive ion mode. PE molecular species were detected by neutral loss
scanning for m/z 141 or 145 in the positive ion
mode. The fatty acid composition of each molecular specie was
determined by daughter ion analysis in the negative ion mode. The
intensities of PC species with equal concentration decreased
significantly as mass increased. To correct spectra for mass
discrimination, PC standards were analyzed at equal concentrations. The
equation derived by plotting intensity versus mass was used to correct raw results: y = y' · [b/([ Western Blot--
Fifty µg of total protein from each cell
line was separated by SDS-polyacrylamide gel electrophoresis (19) and
transferred to nitrocellulose membrane (20). The membranes were probed
with anti-PEMT2 (11) and goat anti-rabbit IgG horseradish peroxidase conjugate. PEMT protein was displayed by a reaction with Supersignal Chemiluminescent Substrate (Pierce) and exposure to x-ray films.
Electrospray ionization tandem mass spectrometry analysis
(18, 21-25) of PC species labeled with specific deuterated precursors allowed us to distinguish the PC species synthesized from the CDP-choline pathway and the PE methylation pathway (Fig.
1A). Different phospholipid
classes were specifically detected by the unique mass/charge
(m/z) ratio of the molecular fragments produced upon argon-induced collision. All PC molecules produced a fragment with
m/z of +184 corresponding to the protonated
phosphocholine head group. All PE molecules were detected by the loss
of a neutral fragment of m/z 141, corresponding
to the uncharged phosphoethanolamine head group.
D4-ethanolamine-labeled PC species with m/z +188
head group were exclusively derived from the PE methylation pathway, and D9-choline-labeled species with m/z +193 head
group were specifically synthesized from the CDP-choline pathway.
The major advantage of this strategy is that the metabolism of major
phospholipid groups can be analyzed from total lipid extracts
without any chemical modification. Thus, the peak intensity of each
lipid reflects a physiological concentration.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
4963.4 · (x
678)] + b)] (y = corrected intensity of each peak,
y' = actual intensity of each peak, b = intensity of the internal di-14:0 PC standard, and x = m/z of each peak).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (32K):
[in a new window]
Fig. 1.
Detection of PC species and deuterium-labeled
PC species by electrospray tandem mass spectrometry. A,
the scheme for specific labeling of PC species with deuterium
precursors (E, ethanolamine; C, choline).
B, McA-RH7777 cells were incubated with 50 µg/ml
D4-ethanolamine and 50 µg/ml D9-choline chloride for 24 h at
37 °C. After lipid extraction, PC species from the total lipid
extract were analyzed by electrospray tandem mass spectrometry. The
unlabeled PC species (head = 184) are shown in the top
panel, and newly synthesized PC species (head = 193) are show
in the bottom panel. C,
time-dependent labeling of PC species from D9-choline.
McA-RH7777 cells were incubated with 50 µg/ml D9-choline chloride for
0, 6, and 24 h at 37 °C, and PC species from the total lipid
extract were analyzed by electrospray tandem mass spectrometry.
D, daughter ion analysis of unlabeled PC with 760 m/z. With a given total mass
(m/z = 760), the 16:0 acyl chain must be
paired with the 18:1 acyl chain. The acyl chain with the lower
intensity of the pair is from the sn-1 position (24). The 18:2 and 20:3
acyl chains must each be paired with alkyl or alkenyl-linked chains.
All experiments in this study were repeated at least twice with similar
results.
To determine whether the incorporation of the D4-labeled choline into PC is a reflection of true PC synthesis from natural choline, we compared the profile of unlabeled PC to that of deuterium-labeled PC in RH7777 cells. RH7777 is a hepatoma-derived cell line in which PEMT activity is absent (7). Thus PC is synthesized exclusively from the CDP-choline pathway in RH7777. The profile of labeled PC species was nearly identical to the profile of endogenous PC species (Fig. 1B). PC species with m/z +193 head group were not detected in the absence of D9-choline (data not shown). Daughter ion analyses of parent ions readily identified the molecular specie(s) under each peak (e.g. Fig. 1C) and were capable of distinguishing ether lipids from diacyl lipids with similar mass.
There are additional findings worthy of notice. First, in addition to the readily identifiable PC species, several phosphocholine-containing lipids didn't match with any deduced structures and m/z of diacyl, 1-alkyl/2-acyl, or 1-alkenyl/2-acyl. The structures of these novel lipids are currently under investigation. Second, because of their biphasic nature, most lyso-PC species were lost in the water phase during lipid extraction according to the method of Bligh and Dyer (17). This problem can be solved by modification of the lipid extraction and lyso-PC species will be a subject of future studies.
To determine whether D4-choline was a viable precursor of PC synthesis, we incubated the RH7777 cells with the labeled choline for various times. A time-dependent accumulation of the labeled PC was observed (Fig. 1D), suggesting that deuterium-labeled choline was indeed a viable precursor for PC synthesis.
To determine the PC profile of the PEMT pathway, we reconstituted the
rat liver PEMT into the rat hepatoma cell line McARH7777, in which PEMT
is absent. Thus, changes in PC synthesis as a specific result of PEMT
expression were determined. The stably expressed PEMT was confirmed by
Western blot analysis using a rat liver PEMT-specific antibody (9)
(Fig. 2A). The reconstituted
PEMT pathway was confirmed by measuring the incorporation of
[3H]ethanolamine into PC isolated by thin layer
chromatography (Fig. 2B). The cells were then labeled
simultaneously with excess D9-choline and D4-ethanolamine for 24 h
at 37 °C. Total lipids were extracted and analyzed by tandem mass
spectrometry. The PC species with head group mass of 188 were derived
exclusively from the PEMT pathway and were detected only in the RH7777
cells that expressed PEMT (Fig. 2F) and not in the control
cells, in which PEMT activity was absent (Fig. 2E). The PC
species with head group mass of 193 from the CDP-choline pathway were
present in both control and PEMT-expressing cell lines and were not
affected by the expression of PEMT (Fig. 2, C and
D).
|
In the PEMT-expressing RH7777 cells, comparison between PC species newly synthesized from the CDP-choline pathway (Fig. 2D) and that from the PE methylation (Fig. 2F) revealed a clear distinction. The major species of the PC derived from the CDP-choline pathway were diacyl 16:0/18:1, 18:0/18:2, and 18:1/18:1, which together made up a majority of the choline-derived PC. On the other hand, PC derived from the methylation pathway contained significantly more long chain, polyunsaturated PC species (18:1/18:1; 18:0/18:2; 18:2/20:4; 18:1/20:4; 18:0/20:4; 18:0/22:6; 18:1/22:5). These findings were in agreement in principal with the previous report that purified PEMT prefers the long chain polyunsaturated PE as substrate (26) for PC synthesis.
To determine whether these distinct profiles of PC in RH7777 cells
reflected the physiological status of PC synthesis in the liver in
which the CDP-choline pathway and PEMT pathway are endogenously co-existent, we performed similar studies in freshly prepared hepatocytes. The primary hepatocytes were labeled with the D4-labeled ethanolamine and D9-choline for 24 h. The total lipids were then extracted and analyzed. The distinction of the PC species from the two
pathways was much more profound in
primary hepatocytes than that of RH7777/PEMT cells (Fig. 3 and Table
I). The PEMT pathway in primary
hepatocytes produced more 38-carbon PC species of 18:2/20:4 and
18:0/20:4 than that in RH7777/PEMT cells. The differences between
RH7777/PEMT and primary hepatocytes may reflect the fact that RH7777
cells are fast dividing cells in which bioactive PC species are turning
over faster than those in the non-dividing hepatocytes.
|
|
Although primary hepatocytes did not divide in cultures, we wondered to
what degree the endogenous PC was replaced by the newly synthesized PC
when excess D4-ethanolamine and D9-choline were present in the culture
media. We labeled the cells for 24 h with both deuterated
precursors. Comparison of unlabeled PC between labeled cells and
unlabeled cells revealed that over 75% of endogenous PC was replaced
by the newly synthesized PC in 24 h (Fig.
4, A and B). Of the
labeled PC, 70% was from the CDP-choline pathway and 30% was from the
PE methylation pathway. The turnover of PC was surprisingly active even
when hepatocytes were essentially in a quiescent state. Comparison of
the residual PC species to that in the unlabeled cells suggests that
the turnover of 16:0/18:2, 16:0-20:4, 18:1/18:1, 18:2-20:4,
18:0/20:4, and 18:0-22:6 species were much more active than that of
16:0/18:1 (Fig. 4, C and D). PC species derived
from PE may be more actively metabolized than the choline-derived PC
species. Additionally, PC species from the methylation pathway
contained a higher percentage of arachidonate (Fig. 3B).
Given the widely spread involvement of arachidonic acid in cellular
regulations, the PC species derived from the PEMT pathway in the liver
may serve as an important source for generating lipids active in
cellular regulation.
|
The biochemical significance of the PEMT pathway in hepatocytes has been of great interest because the CDP-choline pathway is already present in all mammalian cells and is sufficient for PC synthesis. In vivo studies reveal that the PEMT pathway contributes significantly to the survival of rats during complete deficiency of dietary choline (3), suggesting that up-regulation of PEMT pathway might, at least in part, substitute for the role of the CDP-choline pathway. At the cellular level, however, it is surprising that PEMT fails completely to compensate for the defective synthesis of PC. Our current study revealed a molecular basis for biochemical distinction between the CDP-choline pathway and the PEMT pathway. This biochemical distinction apparently lies within the unique compositions of PC species derived from different pathways. Our studies also point out that the CDP-choline pathway synthesized only two or three major species of PC in primary hepatocytes, whereas the PEMT pathway generates at least eight major species of PC with significant efficiency. Therefore, the substrate specificity of the PE methylation pathway is much wider than that of the CDP-choline pathway.
In MT58 cells, CT activity is temperature sensitive (13). Exogenous PC with medium side-chains and high degree of saturation can rescue the mutant cells at the non-permissive temperature (14). However, long-chain and highly unsaturated PC species are "toxic" to the cells. Expression of PEMT in RH7777 displayed a strong and quantitative inhibition of cell growth (6). Our results suggest that the inhibitory effect of PEMT expression in RH7777 cells may be because of the production of long-chain highly unsaturated PC species that are "toxic" to the cells.
The profound distinction in PC molecular species from the two pathways
was unexpected. Nevertheless, given the opposite effects of the two
pathways on hepatocyte proliferation, this distinction in PC species
may account for most, if not all, of the functional difference of the
two pathways. This profound distinction may also reflect a possibility
that both the cholinephosphotransferase and the PE methyltransferase
have preference for fatty acid side-chains in addition to the head
group specificity. However, it cannot be excluded that the distinct
function of the PEMT pathway may also be because of a selective
depletion of PE species as the initial substrates of methylation.
PC species turn over at fast and yet different rates even in
non-dividing cells. With our current strategy of labeling and
detection, all molecular species of PC can be cleanly resolved and
readily quantitated. Not only can the PC species from different
pathways be distinguished unequivocally via labeling with distinctive
precursors, but the newly synthesized PC can be compared with the
pre-existing PC species. The latter feature of this strategy offers a
unique advantage allowing a precise estimation of turnover rates of all
subclasses and all species of phospholipids. Mass spectrometry offers a
resolution of at least 0.01% m/z (or 0.1 dalton
for PC species). Such a resolution is capable of detecting changes of
one proton at either head group or side-chains. Tandem mass
spectrometry eliminates any requirement for separating phospholipid
subclasses before analysis. Thus, chloroform extracts of cells can be
directly analyzed. This advantage appears critical for analysis of
phospholipid species because many separation procedures, such as the
thin layer chromatography, introduce preferential loss of certain
species (results not shown). The sensitivity of this strategy requires
no more than 5,000 cells for analyzing the profiles of phospholipid
species. With the addition of a nanospray device, lipids from as few as
50 cells will provide ample amount of materials for analysis. With such
unprecedented resolution, sensitivity, and simplicity of tandem mass
spectrometry, appropriate labeling with stable isotope precursors shall
reveal many aspects of lipid metabolism that cannot be clearly
addressed by radioactive labeling.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Dennis Vance for providing antibodies to PEMT, Mike Samuel for providing technical assistance for mass spectrometry analysis, and Dr. Tom Thuren and Lynn King for providing the primary rat hepatocytes.
| |
FOOTNOTES |
|---|
* This work was supported by the Signal Transduction and Cellular Function Training Grant CA-09422 (to C. J. D.) from the National Institutes of Health and by the National Institutes of Health Grant RO1-CA85757 (to Z. C.). This project was also supported in part by a grant from American Cancer Society (ACS Grant RG-198A).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 336-716-6185;
Fax: 336-716-7671; E-mail: zhengcui@wfubmc.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PC, phosphatidylcholine; PE, phosphatidylethanolamine; CT, CTP:phosphocholine cytidylyltransferase; CDP, cytidine diphosphate; PEMT, phosphatidylethanolamine methyltransferase; PAGE, polyacrylamide gel electrophoresis; MEM, modified essential medium.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Vance, D. E. (1990) Biochem. Cell Biol. 68, 1151-1165[Medline] [Order article via Infotrieve] |
| 2. | Raetz, C. R. H. (1982) in Phospholipids (Hawthorone, J. N. , and Ansell, G. B., eds) , pp. 435-477, Elsevier Biomedical Press, Amsterdam |
| 3. |
Cui, Z.,
and Vance, D. E.
(1996)
J. Biol. Chem.
271,
2839-2843 |
| 4. | Vance, D. E., and Ridgway, N. D. (1988) Prog. Lipid Res. 27, 61-79[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Vance, D. E., and Walkey, C. J. (1998) Curr. Opin. Lipidol. 9, 125-130[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Cui, Z.,
Houweling, M.,
and Vance, D. E.
(1994)
J. Biol. Chem.
269,
24531-24533 |
| 7. | Cui, Z., and Vance, D. E. (1995) Biochem. J. 312, 939-945 |
| 8. | Tessitore, L., Cui, Z., and Vance, D. E. (1997) Biochem. J. 322, 151-154 |
| 9. | Houweling, M., Cui, Z., and Vance, D. E. (1997) Biochim. Biophys. Acta 1346, 1-9[Medline] [Order article via Infotrieve] |
| 10. | Cui, Z., Shen, Y. J., and Vance, D. E. (1997) Biochim. Biophys. Acta 1346, 10-16[Medline] [Order article via Infotrieve] |
| 11. |
Cui, Z.,
Vance, J. E.,
Chen, M. H.,
Voelker, D. R.,
and Vance, D. E.
(1993)
J. Biol. Chem.
268,
16655-16663 |
| 12. |
Houweling, M.,
Cui, Z.,
and Vance, D. E.
(1995)
J. Biol. Chem.
270,
16277-16282 |
| 13. |
Esko, J. D.,
Wermuth, M. M.,
and Raetz, C. R.
(1981)
J. Biol. Chem.
256,
7388-9325 |
| 14. |
Esko, J. D.,
Nishijima, M.,
and Raetz, C. R.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
1698-1702 |
| 15. |
Davis, R. A.,
Engelhorn, S. C.,
Pangburn, S. H.,
Weinstein, D. B.,
and Steinberg, D.
(1979)
J. Biol. Chem.
254,
2010-2016 |
| 16. |
Chen, C.,
and Okayama, H.
(1987)
Mol. Cell. Biol.
7,
2745-2752 |
| 17. | Bligh, E. G., and Dyer, W. J. (1959) Can. J. Biochem. Physiol. 37, 911-991 |
| 18. | Rouser, G., Siakotas, A. N., and Fleisher, S. (1966) Lipids 1, 85-86 |
| 19. | Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve] |
| 20. |
Towbin, H.,
Staehelin, T.,
and Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354 |
| 21. | Jensen, N. J., Tomer, K. B., and Gross, R. W. (1986) Lipids 21, 580-588[Medline] [Order article via Infotrieve] |
| 22. | Bryant, D. K., Orlando, R. C., Fenselau, C., Sowder, R. C., and Henderson, L. E. (1991) Anal. Chem. 63, 1110-1114[Medline] [Order article via Infotrieve] |
| 23. | Kerwin, J. L., Tuininga, A. R., and Ericsson, L. H. (1994) J. Lipid Res. 35, 1102-1114[Abstract] |
| 24. |
Brügger, B.,
Erben, G.,
Sandhoff, R.,
Wieland, F. T.,
and Lehmann, W. D.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
2339-2344 |
| 25. | Bernstrom, K., Kayganich, K., and Murphy, R. C. (1991) Anal. Biochem. 198, 203-211[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Ridgway, N. D.,
and Vance, D. E.
(1988)
J. Biol. Chem.
263,
16856-16863 |
This article has been cited by other articles:
![]() |
Z. Li and D. E. Vance Thematic Review Series: Glycerolipids. Phosphatidylcholine and choline homeostasis J. Lipid Res., June 1, 2008; 49(6): 1187 - 1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kainu, M. Hermansson, and P. Somerharju Electrospray Ionization Mass Spectrometry and Exogenous Heavy Isotope-labeled Lipid Species Provide Detailed Information on Aminophospholipid Acyl Chain Remodeling J. Biol. Chem., February 8, 2008; 283(6): 3676 - 3687. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Jacobs, S. Lingrell, Y. Zhao, G. A. Francis, and D. E. Vance Hepatic CTP:Phosphocholine Cytidylyltransferase-{alpha} Is a Critical Predictor of Plasma High Density Lipoprotein and Very Low Density Lipoprotein J. Biol. Chem., January 25, 2008; 283(4): 2147 - 2155. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wu, C. Aoyama, S. G. Young, and D. E. Vance Early Embryonic Lethality Caused by Disruption of the Gene for Choline Kinase {alpha}, the First Enzyme in Phosphatidylcholine Biosynthesis J. Biol. Chem., January 18, 2008; 283(3): 1456 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Devlin, R. Singh, R. E. Wade, S. M. Innis, T. Bottiglieri, and S. R. Lentz Hypermethylation of Fads2 and Altered Hepatic Fatty Acid and Phospholipid Metabolism in Mice with Hyperhomocysteinemia J. Biol. Chem., December 21, 2007; 282(51): 37082 - 37090. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Vance, Z. Li, and R. L. Jacobs Hepatic Phosphatidylethanolamine N-Methyltransferase, Unexpected Roles in Animal Biochemistry and Physiology J. Biol. Chem., November 16, 2007; 282(46): 33237 - 33241. [Full Text] [PDF] |
||||
![]() |
T. W. Mitchell, K. Ekroos, S. J. Blanksby, A. J. Hulbert, and P. L. Else Differences in membrane acyl phospholipid composition between an endothermic mammal and an ectothermic reptile are not limited to any phospholipid class J. Exp. Biol., October 1, 2007; 210(19): 3440 - 3450. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. B. Bleijerveld, J. F. H. M. Brouwers, A. B. Vaandrager, J. B. Helms, and M. Houweling The CDP-ethanolamine Pathway and Phosphatidylserine Decarboxylation Generate Different Phosphatidylethanolamine Molecular Species J. Biol. Chem., September 28, 2007; 282(39): 28362 - 28372. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Jacobs, S. Lingrell, J. R. B. Dyck, and D. E. Vance Inhibition of Hepatic Phosphatidylcholine Synthesis by 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside Is Independent of AMP-activated Protein Kinase Activation J. Biol. Chem., February 16, 2007; 282(7): 4516 - 4523. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Hartz, K. M. Nieman, R. L. Jacobs, D. E. Vance, and K. L. Schalinske Hepatic Phosphatidylethanolamine N-Methyltransferase Expression Is Increased in Diabetic Rats J. Nutr., December 1, 2006; 136(12): 3005 - 3009. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M Stead, J. T Brosnan, M. E Brosnan, D. E Vance, and R. L Jacobs Is it time to reevaluate methyl balance in humans? Am. J. Clinical Nutrition, January 1, 2006; 83(1): 5 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, L. B. Agellon, and D. E. Vance Phosphatidylcholine Homeostasis and Liver Failure J. Biol. Chem., November 11, 2005; 280(45): 37798 - 37802. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Jacobs, L. M. Stead, C. Devlin, I. Tabas, M. E. Brosnan, J. T. Brosnan, and D. E. Vance Physiological Regulation of Phospholipid Methylation Alters Plasma Homocysteine in Mice J. Biol. Chem., August 5, 2005; 280(31): 28299 - 28305. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Shields, S. Lingrell, L. B. Agellon, J. T. Brosnan, and D. E. Vance Localization-independent Regulation of Homocysteine Secretion by Phosphatidylethanolamine N-Methyltransferase J. Biol. Chem., July 22, 2005; 280(29): 27339 - 27344. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Vance and D. E. Vance Metabolic Insights into Phospholipid Function Using Gene-targeted Mice J. Biol. Chem., March 25, 2005; 280(12): 10877 - 10880. [Full Text] [PDF] |
||||
![]() |
S. Jackowski and P. Fagone CTP:Phosphocholine Cytidylyltransferase: Paving the Way from Gene to Membrane J. Biol. Chem., January 14, 2005; 280(2): 853 - 856. [Full Text] [PDF] |
||||
![]() |
R. L. Jacobs, C. Devlin, I. Tabas, and D. E. Vance Targeted Deletion of Hepatic CTP:phosphocholine Cytidylyltransferase {alpha} in Mice Decreases Plasma High Density and Very Low Density Lipoproteins J. Biol. Chem., November 5, 2004; 279(45): 47402 - 47410. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kulinski, D. E. Vance, and J. E. Vance A Choline-deficient Diet in Mice Inhibits neither the CDP-choline Pathway for Phosphatidylcholine Synthesis in Hepatocytes nor Apolipoprotein B Secretion J. Biol. Chem., June 4, 2004; 279(23): 23916 - 23924. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yuan and C. Kent Identification of Critical Residues of Choline Kinase A2 from Caenorhabditis elegans J. Biol. Chem., April 23, 2004; 279(17): 17801 - 17809. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Davis, P. W. Stacpoole, J. Williamson, L. S. Kick, E. P. Quinlivan, B. S. Coats, B. Shane, L. B. Bailey, and J. F. Gregory III Tracer-derived total and folate-dependent homocysteine remethylation and synthesis rates in humans indicate that serine is the main one-carbon donor Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E272 - E279. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, P. H. Links, J. K. Ngsee, K. Tran, Z. Cui, K. W. S. Ko, and Z. Yao Localization of Low Density Lipoprotein Receptor-related Protein 1 to Caveolae in 3T3-L1 Adipocytes in Response to Insulin Treatment J. Biol. Chem., January 16, 2004; 279(3): 2221 - 2230. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ekroos, C. S. Ejsing, U. Bahr, M. Karas, K. Simons, and A. Shevchenko Charting molecular composition of phosphatidylcholines by fatty acid scanning and ion trap MS3 fragmentation J. Lipid Res., November 1, 2003; 44(11): 2181 - 2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Watkins, X. Zhu, and S. H. Zeisel Phosphatidylethanolamine-N-methyltransferase Activity and Dietary Choline Regulate Liver-Plasma Lipid Flux and Essential Fatty Acid Metabolism in Mice J. Nutr., November 1, 2003; 133(11): 3386 - 3391. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Noga and D. E. Vance Insights into the requirement of phosphatidylcholine synthesis for liver function in mice J. Lipid Res., October 1, 2003; 44(10): 1998 - 2005. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Shields, J. Y. Altarejos, X. Wang, L. B. Agellon, and D. E. Vance Molecular Dissection of the S-Adenosylmethionine-binding Site of Phosphatidylethanolamine N-Methyltransferase J. Biol. Chem., September 12, 2003; 278(37): 35826 - 35836. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sehayek, R. Wang, J. G. Ono, V. S. Zinchuk, E. M. Duncan, S. Shefer, D. E. Vance, M. Ananthanarayanan, B. T. Chait, and J. L. Breslow Localization of the PE methylation pathway and SR-BI to the canalicular membrane: evidence for apical PC biosynthesis that may promote biliary excretion of phospholipid and cholesterol J. Lipid Res., September 1, 2003; 44(9): 1605 - 1613. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Noga and D. E. Vance A Gender-specific Role For Phosphatidylethanolamine N-Methyltransferase-derived Phosphatidylcholine in the Regulation of Plasma High Density and Very Low Density Lipoproteins in Mice J. Biol. Chem., June 6, 2003; 278(24): 21851 - 21859. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Aleynik and C. S. Lieber POLYENYLPHOSPHATIDYLCHOLINE CORRECTS THE ALCOHOL-INDUCED HEPATIC OXIDATIVE STRESS BY RESTORING S-ADENOSYLMETHIONINE Alcohol Alcohol., May 1, 2003; 38(3): 208 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shimada, T. Morita, and K. Sugiyama Dietary Eritadenine and Ethanolamine Depress Fatty Acid Desaturase Activities by Increasing Liver Microsomal Phosphatidylethanolamine in Rats J. Nutr., March 1, 2003; 133(3): 758 - 765. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Noga, L. M. Stead, Y. Zhao, M. E. Brosnan, J. T. Brosnan, and D. E. Vance Plasma Homocysteine Is Regulated by Phospholipid Methylation J. Biol. Chem., February 14, 2003; 278(8): 5952 - 5955. [Abstract] [Full Text] [PDF] |
||||